Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy

被引：11
|
作者：
Copur, Mehmet Sitki [1 ]
Crockett, David [1 ]
Gauchan, Dron [1 ]
Ramaekers, Ryan [1 ]
Mleczko, Kris [2 ]
机构：
[1] CHI Hlth St Francis Canc Treatment Ctr, Grand Isl, NE 68803 USA
[2] CHI Hlth St Francis Med Ctr, Grand Isl, NE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 19期
关键词：
REARRANGEMENT; ASSOCIATION; PATHOLOGY; COLLEGE;
D O I：
10.1200/JCO.2018.78.8240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2006 / +
页数：2
相关论文
共 50 条
  • [41] Targeted therapy of lung cancer
    Lee, Kye Young
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (05): : 483 - 491
  • [42] Addressing gaps in molecular testing for patients with lung cancer
    King, Jennifer C.
    Ciupek, Andrew
    Perloff, Tara
    Blanchard, Ashley
    Mason, Kimberly
    Blais, Edik
    Halverson, David
    Bender, Joseph
    Madhavan, Subha
    Petricoin, Emanuel
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [43] Tumor Mutation Burden and Efficacy of Molecular Targeted Therapy in Lung Cancer
    Arai, K.
    Sakamoto, T.
    Yamane, K.
    Hirayama, Y.
    Teruya, Y.
    Yanai, M.
    Kinoshita, N.
    Yamaguchi, K.
    Makino, H.
    Kodani, M.
    Igishi, T.
    Yamasaki, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S846 - S847
  • [44] New Molecular Targeted Therapies Integrated With Radiation Therapy in Lung Cancer
    Provencio, Mariano
    Sanchez, Antonio
    Garrido, Pilar
    Valcarcel, Francisco
    [J]. CLINICAL LUNG CANCER, 2010, 11 (02) : 91 - 97
  • [45] Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
    Samadder, N. Jewel
    Riegert-Johnson, Douglas
    Boardman, Lisa
    Rhodes, Deborah
    Wick, Myra
    Okuno, Scott
    Kunze, Katie L.
    Golafshar, Michael
    Uson, Pedro L. S., Jr.
    Mountjoy, Luke
    Ertz-Archambault, Natalie
    Patel, Neej
    Rodriguez, Eduardo A.
    Lizaola-Mayo, Blanca
    Lehrer, Michael
    Thorpe, Cameron S.
    Yu, Nathan Y.
    Esplin, Edward D.
    Nussbaum, Robert L.
    Sharp, Richard R.
    Azevedo, Cindy
    Klint, Margaret
    Hager, Megan
    Macklin-Mantia, Sarah
    Bryce, Alan H.
    Bekaii-Saab, Tanios S.
    Sekulic, Aleksandar
    Stewart, Keith A.
    [J]. JAMA ONCOLOGY, 2021, 7 (02) : 230 - 237
  • [46] Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer
    Lin, Rixu
    Li, Yida
    Lin, Yi
    Tian, Wenyi
    Jiang, Lei
    Li, Jianmin
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (07) : 397 - 405
  • [47] The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer
    Tobin, N. P.
    Foukakis, T.
    De Petris, L.
    Bergh, J.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2015, 278 (06) : 545 - 570
  • [48] Molecular Testing of Lung Cancer
    Trabolsi, A.
    Rodriguez, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] The role of pathologist in cancer patients selection for EGFR-targeted therapy
    Olszewski, Wojciech P.
    Olszewski, Wlodzimierz T.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (05): : 228 - 235
  • [50] Targeted Therapy and Immunotherapy for Lung Cancer
    Naylor, Evan C.
    Desani, Jatin K.
    Chung, Paul K.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 601 - +
12345